Author(s):
Shikha Baghel Chauhan, Vaishnavi Gupta
Email(s):
shikha.pharma@gmail.com
DOI:
10.5958/0974-360X.2020.00369.8
Address:
Shikha Baghel Chauhan*, Vaishnavi Gupta
Assistant Professor, Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 4,
Year - 2020
ABSTRACT:
Liposomes as artificial colloidal vesicular structure having hydrophilic core in a lipid bilayer membrane became one of the most tremendously explored drug delivery system. These spherical vesicles consist of amphiphilic molecule like cholesterol, sterols and can be used to deliver both hydrophilic drugs as well as lipophilic drug. These vesicles are differentiated on the basis of size, composition, method of preparation and application. Liposomes are biodegradable, nonimmunogenic, biocompatible, provide targeted and prolonged release, change pharmacokinetic and pharmacodynamic attribute of drug, they find wide clinical application as diagnostic, antimicrobial, anticancer, vaccine adjuvant and cosmetics. Expanding application show promising sign for future development in liposome. The present review provides information about liposome in drug deliver, their composition, structure, different method of preparation, various types of liposome, clinical applications of liposome, strategies, marketed formulation.
Cite this article:
Shikha Baghel Chauhan, Vaishnavi Gupta. Recent Advances in Liposome. Research J. Pharm. and Tech. 2020; 13(4):2051-2056. doi: 10.5958/0974-360X.2020.00369.8
Cite(Electronic):
Shikha Baghel Chauhan, Vaishnavi Gupta. Recent Advances in Liposome. Research J. Pharm. and Tech. 2020; 13(4):2051-2056. doi: 10.5958/0974-360X.2020.00369.8 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-4-79
REFERENCES:
1. Bangham A, Standish MM, Watkins J. Diffusion of univalent ion across the lamellae of swallon phospholipid. J. Mol. Bio 1965;13(27):238
2. Vyas SP, Khar RK 2013.The theory and Practice of Industrial Pharmacy. New Delhi, India: CBS Publishers and Distributor.
3. Aqil M Samad A, Sultana Y. Liposomal drug delivery system: An update review. Curr Drug deliv.2007;4(4):279-305
4. TorchilinVP. Multifunctional Nanocarriers. Adv Drug Deliv Rev.2006;58(14):1532-55
5. Al –Jamal W.T, Kosteorelos K, Liposome From a clinically established drug delivery to the nanoparticle, Platform for theragonistic. Nanomedicine. Acc.Chem Res.2011;44(10):1094-104
6. Allen T.M, Cullis P.R. Liposomal drug delivery system: From concept to clinical application. Adv Drug deliv Rev.2013;65(1): 36-48
7. Kalepu S, Nekkant V. Recent advances liposomal drug delivery: a review. Int J of Res Pharm and Nano sci .2014,3(3):159-169
8. Aukunuru J. Joginpol Preparation, Characterization and evaluation of hepatoprotective activity of intravenous liposomal formulation, of bis –dimethoxy curcumin analogue. Int. J. of Drug Dev. and Res.2009;1(1):37-46
9. Chanda H, Das P, et al. “Development and evaluation of liposomes of fluconazole” JPBMS. 2011; 5 (27)1:-9
10. Devi M, Kumar MS, Mahadevan, Nitharsana, Amphotericin-B loaded vesicular systems for the treatment of topical fungal infection. Int. J. Recent Adv. Pharm.Res. 2011; 4: 37-46
11. Marrapati S, Reddy P, Uma Shankar K. A Review on liposome. Int. J. of Pharm and Nano sci. 2014;3[3]:159-169
12. Kant S, Kumar S, Parashar B. A Complete review on Liposomes, Int. Res. J. of Pharm. 2012;3[7] :10-16
13. Akbarzadeh A, Rezaei-Sadabady-R, Davaran S, Joo SB , Zarghami N, Hanifehpur ,et.al. Liposome: Classification, Preparation and applications. Nanoscale Res. Lett,2013, 8(1):102
14. Sharma A, Sharma U.S. Liposome in drug delivery Progress and Limitations. Int J. Pharm.1997; 154(2) :123-140
15. Cattel L, Dosia F, Immardiano M.L. Sheath liposome Review of Basic Science and Clinical Applications existing and poterntial. Int J Nano med. 2006;1(3):297-315
16. Dutta R, Kumar S, Pandey D, Yadav D Pandey . Liposome for drug delivery. J Biotechol Biomater. 2017; 7[4]:3
17. Rawat S, Sahdev A.k, Sethi B, Sheokand R. A Study of liposome: Classification Teqnique and importance. Int J Pharmacy and Pharm Sci .2017;2 (6) :55-60
18. Ali AE , Sharma D, Trivedi LR; An Updated Review on: Liposomes as drug delivery system. PharmaTutor.2018; 6(2): 50-62;
19. Deshmukh et.al. A Review on: Liposome. World journal of pharmacy and pharmaceutical sciences. 2016;5(3):506-517
20. Kalepu S. et.al Liposomal drug delivery system- A Comprehensive Review. Int J of Drug dev.& Res. 2013;5(4):62-65
21. Bhandari A.K ,Dua JS, Rana A.C . Liposome; Method of Preparation and Applications, Int J Pharma Stud & Res. 201;,3 (2):14-22
22. Arunachalam A, Babu A Prathap M, Srikanth S, Sivaiah P. Thulasirmaraju T.V. Liposome: A Novel drug delivery system. IJB ,2012;3(1) 5-16
23. Anwekar H, Patel S, Singhai A.K. Liposome as drug carrier. Int J. of Pharm. & Life Sci. 2011;2 (7):945-951
24. Mishra D.N, Sharma A.K. , Sharma V.K. Shrivastava B. Liposome: Present Prospective and Future challenge. International journal of current pharmaceutical review and research.2010;1(20),6-15
25. Mahapatra A.K. Progress with liposomal drug delivery systems: Formulation to therapy. Der Pharmacia Lettre 2014; 6(3):110-128
26. Joshi A.J, Patel R.P. Liposome: Emerging Trends in novel drug delivery with present and future challenges. International Journal of Pharmaceutical and Biological Achieves. 2015;6[2]:3-8
27. Blauza L , Charcosset C, Fessi H, LauniA, Jaafar- Maalej C, Sfar S, et.al. Preparation and Characterization and Application of Liposome: State of Art. J Colloid Sci. and biotechnol.2012;1:147-168
28. Agrawal S, Jawade M.A, Khan M.J, A Review on liposome. Int J. Adv Res in Pharm & Biosci.2012;2(4):453-464
29. Popovska O, Simonovska J, Kavravski K, Rafajilovska V. An Overview Method for preparation and characterization of liposome as drug delivery system. International journal of pharmaceutical and phytochemical research.2013;3(3):182-189
30. Karami N, Moghimipour E, Salimi A, Liposome as novel drug delivery system: Fundamental and Pharmaceutical Application. Asian Journal of Pharmaceutics .2018;12(1):S31-S41
31. Achim M, Precup C, et al “Thermosensitive liposomes containing doxorubicin. Preparation and in vitro evaluation. Farmacia.2009; 57 (6): 703-710.
32. Moghiripour E, Salami A, Mojezi M. Formulation and evaluation of liposomes for transdermal delivery of celecoxib. Jundispur J Nat Pharm Prod .2015;10(1)
33. Da C, M oraes M. Encapsulation of 5fluorouracil liposome for topical administration. Moringa.2003; 25(1):53-61
34. Khar W, Pethe AS, Talib Y.A. Preparation of Drug loaded liposome. Journal of Global biosciences. 2016; 5(6): 4221-4226
35. Pradhan B, Kumar N, Saha S, Roy A, Liposome ; Method of Preparation , Advantages evaluation and its application. J Appl Pharm Res. 2015;3 (3):1-8
36. Dwivedi V , Verma S. Review on preparation and characterization of Liposome with application , Journal of scientific and Innovative Research, 2013, 2(2): 486-508
37. Aher SS, Bodke AR, Saudagar R.B. A review on the liposome. Int J Pharma & Chem Res. 2017;3 (2) :120-127
38. Sriwongsitanout S, Ueno M. Effect of Freeze Thawing Process on size and lamellarity of PEG –lipid liposome. The Open colloidal science journal.2011;4:1-6
39. Andriev V , Diab R, Elaissari A, Fessi H, Maalej CJ. Ethanol Injection Method For hydrophilic and lipophilic loaded Drug. Journal of Liposomal Research. 2010; 20(13): 228-243
40. Bansal B.K, Pareek R Rewar S, Singh C.J, Sharma AK. A vital role of Liposome’s on controlled and Novel Drug Delivery International Journal of Pharmaceutical & Biological Archieves. 2014; 5(2):51-63
41. Kataria S, Sandhu P, Bilandi A, Middha A, Kapoor B Sheath Liposome: A lo International Journal of Research in Ayurveda & Pharmacy. 2011; 2(5):1534-1538
42. Ahmad FR, Amran M.S, Hossen MN Saheen S.M, UI-Islam MA; Liposome as a carrier for advanced delivery .Pak. J.Bio Sci. 2006; 9 (6):1534-1538
43. Hyode K et.al Development of liposomal anticancer drugs Bio. Pharm Bull. 201;36(5):703-707
44. Balbake V, 9, Kommineni N, Khan W .Liposomal formulation in clinical use; An updated review. Pharmaceutics. 2017; 9(12): 2-33
45. Hu J.Y. et.al. Advances in liposomal drug delivery in the field of chemotherapy, Clinics in Oncology. Chemotherapy and Radiotherapy.2016;1(1): 1-10 Bagui M , Mishra G.P Mitra A.K, Tambali V. Recent application of liposomes in ophthalmic drug delivery: an update review. Journal of drug delivery .2011;1(1):14
46. Agrawal R et.al. Liposome in topical ophthalmic drug delivery ; an update. Informa healthcare. 2016;23(4):1075-91.
47. Kulkarni P.R, Vaidya K, Liposome A novel drug delivery system. Int J curr pharma Res. 2011;3(2): 11-18
48. Martin F, Bawikas T. The challenges of liposome in gene therepy. Gene therapy and molecular biology 1998,1(1);173-214
49. Chu C .J, Dijkstra J, Hong K, Loi M.Z. , Svoka F.C. Efficiency of cytoplasmic delivery by pH sensitive liposome to cell in culture. Pharmaceutical Research. 1990; 7: 824-839
50. Ferreira DS, et.al. pH sensitive liposomes for drug delivery in cancer treatrment. Ther Deliv. 2013; 4(9):1099-123
51. Brigham K.L. Berry L.C , Christmann B Meyrick A.B, Expression of Prokaryotic gene in cultured lung endothelial cell after lipofection with plasmid vector .American Journal of respiratory cell and molecular biology.1989;1(1): 95-100
52. Boone L.R Innes C L, Langerhans R Smith P.B, Tindal K.R. Cationic Liposome (Lipofectin) mediate retroviral injection in the absence of specific receptor. Journal of Virology .1990;64(1):957-961
53. Ashtani H.R, Lashgaril N, Ali M .et.al Liposomes in Cosmetic Journal of Skin Stem Cell.2016:1-16
54. Tiwari R. Liposome; The Novel approach in cosmaceuticals. World Journal of Pharmacy and Pharmaceutical Sciences. 2015 6(4): 1616-1640
55. Patel M.C , Patel H.K., Patel S.R, Suthar R.M. Liposome as Topical delivery system. International Journal of Pharmaceutical and Chemical sciences. 2012; 1(1);1-10
56. Bhaskaran S Lakshami P.K, Saroja C.H. Recent Trends in Vaccine delivery Systems. Int J Pharm Inves.2011;1(2) 64-74
57. Schwender R.A. Liposomes as vaccine delivery system: a review recent advances .Ther Adv vaccines. 2014,2(6),159-182
58. Torchilin V, Recent advances with liposome as pharmaceutical carrier. Nature Review/Drug discovery. 2005;1(4) :145-156
59. Hwang K, LuY Xing H. Recent Development of Liposome as nanocarrier for thernostic applications, Theragonistic,2016,6(9): 1336-1352
60. SilinderM, Erologans S, Ozer A, Maia S. Liposome and their applications in molecular imaging. Journal of Drug Targeting .2012;20(5):401-415
61. Okar R.S Uhumwanghao. M.V. Current trends in production and biomedical application of Liposomes: a review. Journal of Medicine and Biomedicine Research .2005; 4(1);25
62. Jagani R., Kumbhani K, Vyas H. Enhanced activity of antibiotics by liposomal drug delivery. Advanced Nanosciences and Technology: An International Journal. 2015;1(1):67-77
63. Abeylath SC, Turos E. Drug delivery approaches to overcome bacterial resistance to beta lactam antibiotics. Exp. Opin Drug Deliv. 2008;5(9) :31-49
64. Dayem S.A., Elshemay W.M, Shafaa M.W. Osman H.M. In vitro antibacterial activity of liposomal cephalexin against Staphylococcus aureus. Romanian J. Biophys.2008;18: 293-300.